Lipid-Lowering Agents in Older Individuals: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

Comparison of Five Major Guidelines for Statin Use in Primary Prevention in a Contemporary General Population

(2018) Martin Bødtker Mortensen et al.   ANNALS OF INTERNAL MEDICINE

Appropriateness of statin prescription in the elderly

(2018) M. Ruscica et al.   European Journal of Internal Medicine

Primary Prevention With Statins in the Elderly

(2018) Martin Bødtker Mortensen et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

A Systematic Review and Meta-analysis of the Factors Associated With Nonadherence and Discontinuation of Statins Among People Aged ≥65 Years

(2018) Richard Ofori-Asenso et al.   JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES

The GRADE Working Group clarifies the construct of certainty of evidence

(2017) Monica Hultcrantz et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Effect of Statin Treatment vs Usual Care on Primary Cardiovascular Prevention Among Older Adults

(2017) Benjamin H. Han et al.   JAMA Internal Medicine

Interpretation of the evidence for the efficacy and safety of statin therapy

(2016) Rory Collins et al.   LANCET

Statins for Primary Prevention of Cardiovascular Disease in Elderly Patients: Systematic Review and Meta-Analysis

(2015) Monica Teng et al.   DRUGS & AGING

Aggressive Lipid Management in Very Elderly Adults: Less Is More

(2014) Michael W. Rich   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Rosuvastatin for Primary Prevention in Older Persons With Elevated C-Reactive Protein and Low to Average Low-Density Lipoprotein Cholesterol Levels: Exploratory Analysis of a Randomized Trial

(2013) Robert J. Glynn   ANNALS OF INTERNAL MEDICINE

Influence of Reported Study Design Characteristics on Intervention Effect Estimates From Randomized, Controlled Trials

(2013) Jelena Savović et al.   ANNALS OF INTERNAL MEDICINE

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults

(2013) Neil J. Stone et al.   CIRCULATION

Efficacy and safety evaluation of intensive statin therapy in older patients with coronary heart disease: a systematic review and meta-analysis

(2013) Y. L. Yan et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

MRI-measured regression of carotid atherosclerosis induced by statins with and without niacin in a randomised controlled trial: the NIA plaque study

(2013) Christopher T Sibley et al.   HEART

Benefits of Statins in Elderly Subjects Without Established Cardiovascular Disease

(2013) Gianluigi Savarese et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20 536 high-risk individuals: a randomised controlled trial

(2013) Heart Protection Study Collaborative Group   LANCET

Impact of atorvastatin among older and younger patients in the Anglo-Scandinavian Cardiac Outcomes Trial Lipid-Lowering Arm

(2011) David J Collier et al.   JOURNAL OF HYPERTENSION

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

(2010)   LANCET

Comparison of Efficacy and Safety of Atorvastatin (80 mg) to Simvastatin (20 to 40 mg) in Patients Aged

(2009) Matti J. Tikkanen et al.   AMERICAN JOURNAL OF CARDIOLOGY

Impact of High-Dose Atorvastatin in Coronary Heart Disease Patients Age 65 to 78 Years

(2009) Michael J. Koren et al.   CLINICAL CARDIOLOGY

The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

(2009) Alessandro Liberati et al.   PLOS MEDICINE

Statins for Secondary Prevention in Elderly Patients

(2008) Jonathan Afilalo et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack

(2008) S. Chaturvedi et al.   NEUROLOGY